|
End-of-day quote
NYSE
|
||
| - USD | - |
|
| 24/04/14 | PERNOD RICARD : looks for more bolt-on deals after U.S. buy | RE |
| 23/04/14 | Allergan : Activist investors see Ackman-Valeant deal as a model to follow | RE |
| Manager | Title | Age | Since |
|---|---|---|---|
Greg Hughes
CEO | Chief Executive Officer | - | 01/10/2023 |
Gina Rossi
DFI | Director of Finance/CFO | 54 | 01/04/2017 |
John Rosair
PRN | Corporate Officer/Principal | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | - | 01/01/2015 | |
Haruhisa Inada
BRD | Director/Board Member | - | 30/04/2014 |
Shingo Torii
BRD | Director/Board Member | 73 | 01/05/2014 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.14% | -1.60% | -13.80% | -31.81% | 230B | ||
| -0.95% | -0.47% | -42.02% | -55.51% | 40.29B | ||
| -2.50% | -1.35% | -41.84% | -54.00% | 20.21B | ||
| -2.02% | -1.77% | -44.62% | -68.19% | 15.49B | ||
| -0.59% | +1.32% | +8.17% | +41.25% | 10.55B | ||
| -1.47% | -1.55% | -44.86% | -71.28% | 8.41B | ||
| +0.27% | +0.37% | +11.23% | -45.47% | 8.16B | ||
| -5.31% | -2.26% | -40.57% | -66.77% | 6.42B | ||
| -1.25% | -2.99% | -31.15% | -55.25% | 5B | ||
| Average | -1.67% | -0.77% | -26.61% | -45.23% | 38.32B | |
| Weighted average by Cap. | -1.28% | -1.26% | -20.37% | -37.55% |
- Stock Market
- Stocks
- Stock
- BEAM Stock
Select your edition
All financial news and data tailored to specific country editions
















